Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd

<< Previous

Bullboard Posts

Next >>

Post by loonietuneson Dec 02, 2014 10:12pm

140 Views

Post# 23188578

Not sure if this will load?

We're on page 39 if it doesn't not new but interesting as we're still showing up as an independent junior. https://www.visualcapitalist.com/wp-content/uploads/2013/11/global-gold-mine-and-deposit-rankings-2013.pdf

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading